Compare PLCE & SRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PLCE | SRTS |
|---|---|---|
| Founded | 1969 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Clothing/Shoe/Accessory Stores | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 73.8M | 65.5M |
| IPO Year | 1997 | 2016 |
| Metric | PLCE | SRTS |
|---|---|---|
| Price | $3.23 | $3.59 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | $3.50 | ★ $7.00 |
| AVG Volume (30 Days) | ★ 235.8K | 76.0K |
| Earning Date | 04-10-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 11.48 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $27,482,000.00 |
| Revenue This Year | N/A | $2.00 |
| Revenue Next Year | $4.41 | $34.23 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.76 | $2.82 |
| 52 Week High | $9.56 | $5.92 |
| Indicator | PLCE | SRTS |
|---|---|---|
| Relative Strength Index (RSI) | 48.32 | 45.24 |
| Support Level | $2.90 | $3.66 |
| Resistance Level | $3.81 | $4.52 |
| Average True Range (ATR) | 0.19 | 0.27 |
| MACD | 0.01 | -0.03 |
| Stochastic Oscillator | 52.04 | 58.90 |
Children's Place Inc operate an omni-channel children's specialty portfolio of brands in North America. It designs, contract to manufacture, and sell fashionable, high-quality apparel, accessories and footwear predominantly at value prices under proprietary The Children's Place, Place, Baby Place, Gymboree, Sugar & Jade, and PJ Place brand names. The Company classifies its business into two segments: The Children's Place U.S. and The Children's Place International.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.